- Home
- NKTX vs ZENV Comparison
NKTX vs ZENV Comparison
Compare NKTX & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- ZENV
- Stock Information
- Founded
- NKTX 2015
- ZENV 2005
- Country
- NKTX United States
- ZENV Brazil
- Employees
- NKTX N/A
- ZENV N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- NKTX Health Care
- ZENV Technology
- Exchange
- NKTX Nasdaq
- ZENV Nasdaq
- Market Cap
- NKTX 170.8M
- ZENV 146.3M
- IPO Year
- NKTX 2020
- ZENV 2021
- Fundamental
- Price
- NKTX $2.47
- ZENV $2.33
- Analyst Decision
- NKTX Strong Buy
- ZENV
- Analyst Count
- NKTX 5
- ZENV 0
- Target Price
- NKTX $15.20
- ZENV N/A
- AVG Volume (30 Days)
- NKTX 1.5M
- ZENV 162.5K
- Earning Date
- NKTX 11-07-2024
- ZENV 11-18-2024
- Dividend Yield
- NKTX N/A
- ZENV N/A
- EPS Growth
- NKTX N/A
- ZENV N/A
- EPS
- NKTX N/A
- ZENV N/A
- Revenue
- NKTX N/A
- ZENV $173,594,726.00
- Revenue This Year
- NKTX N/A
- ZENV $25.56
- Revenue Next Year
- NKTX N/A
- ZENV $6.02
- P/E Ratio
- NKTX N/A
- ZENV N/A
- Revenue Growth
- NKTX N/A
- ZENV 23.49
- 52 Week Low
- NKTX $2.08
- ZENV $1.00
- 52 Week High
- NKTX $16.24
- ZENV $3.88
- Technical
- Relative Strength Index (RSI)
- NKTX 50.49
- ZENV 54.30
- Support Level
- NKTX $2.19
- ZENV $2.29
- Resistance Level
- NKTX $2.70
- ZENV $2.77
- Average True Range (ATR)
- NKTX 0.15
- ZENV 0.32
- MACD
- NKTX 0.03
- ZENV -0.02
- Stochastic Oscillator
- NKTX 54.90
- ZENV 36.94
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.